Anlotinib in patients with recurrent platinum resistant/refractory ovarian cancer: a prospective, single arm, phase II study

作者：Wenbin Shen, Chuyu Jing, Wenjuan Tian, Wei Zhang, Yu Ren, Boer Shan, Huaying Wang · 发表于：International Journal of Gynecological Cancer · 年份：2023 · DOI：10.1136/ijgc-2023-004777 · 被引用次数：9 · 研究领域：Lung Cancer Research Studies、PARP inhibition in cancer therapy、Ovarian cancer diagnosis and treatment